Skip to main content
Top
Published in: Diabetologia 6/2016

Open Access 01-06-2016 | Article

Variants in the FTO and CDKAL1 loci have recessive effects on risk of obesity and type 2 diabetes, respectively

Authors: Andrew R. Wood, Jessica Tyrrell, Robin Beaumont, Samuel E. Jones, Marcus A. Tuke, Katherine S. Ruth, Hanieh Yaghootkar, Rachel M. Freathy, Anna Murray, Timothy M. Frayling, Michael N. Weedon, The GIANT consortium

Published in: Diabetologia | Issue 6/2016

Login to get access

Abstract

Aims/hypothesis

Genome-wide association (GWA) studies have identified hundreds of common genetic variants associated with obesity and type 2 diabetes. These studies have usually focused on additive association tests. Identifying deviations from additivity may provide new biological insights and explain some of the missing heritability for these diseases.

Methods

We performed a GWA study using a dominance deviation model for BMI, obesity (29,925 cases) and type 2 diabetes (4,040 cases) in 120,286 individuals of British ancestry from the UK Biobank study. We also investigated whether single nucleotide polymorphisms previously shown to be associated with these traits showed any enrichment for departures from additivity.

Results

Known obesity-associated variants in FTO showed strong evidence of deviation from additivity (p DOMDEV = 3 × 10−5) through a recessive effect of the allele associated with higher BMI. The average BMI of individuals carrying zero, one or two BMI-raising alleles was 27.27 (95% CI 27.22, 27.31) kg/m2, 27.54 (95% CI 27.50, 27.58) kg/m2 and 28.07 (95% CI 28.00, 28.14) kg/m2, respectively. A similar effect was observed in 105,643 individuals from the GIANT Consortium (p DOMDEV = 0.003; meta-analysis p DOMDEV = 1 × 10−7). For type 2 diabetes, we detected a recessive effect (p DOMDEV = 5 × 10−4) at CDKAL1. Relative to homozygous non-risk allele carriers, homozygous risk allele carriers had an OR of 1.48 (95% CI 1.32, 1.65), while the heterozygous group had an OR of 1.06 (95% CI 0.99, 1.14), a result consistent with that of a previous study. We did not identify any novel associations at genome-wide significance.

Conclusions/interpretation

Although we found no evidence of widespread non-additive genetic effects contributing to obesity and type 2 diabetes risk, we did find robust examples of recessive effects at the FTO and CDKAL1 loci.

Access to research materials

Summary statistics are available at www.​t2diabetesgenes.​org and by request (a.r.wood@exeter.ac.uk). All underlying data are available on application from the UK Biobank.
Appendix
Available only for authorised users
Literature
1.
go back to reference Frayling TM, Timpson NJ, Weedon MN et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889–894CrossRefPubMedPubMedCentral Frayling TM, Timpson NJ, Weedon MN et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889–894CrossRefPubMedPubMedCentral
3.
go back to reference Morris AP, Voight BF, Teslovich TM et al (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44:981–990CrossRefPubMedPubMedCentral Morris AP, Voight BF, Teslovich TM et al (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44:981–990CrossRefPubMedPubMedCentral
4.
go back to reference Diabetes Genetics Replication and Meta-Analysis (DIAGRAM) Consortium, Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium et al (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 46:234–244CrossRef Diabetes Genetics Replication and Meta-Analysis (DIAGRAM) Consortium, Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium et al (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 46:234–244CrossRef
5.
go back to reference Speliotes EK, Willer CJ, Berndt SI et al (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42:937–948CrossRefPubMedPubMedCentral Speliotes EK, Willer CJ, Berndt SI et al (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42:937–948CrossRefPubMedPubMedCentral
6.
go back to reference Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589CrossRefPubMedPubMedCentral Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589CrossRefPubMedPubMedCentral
7.
go back to reference Wellcome Trust Case Control Consortium, Burton PR, Clayton DG et al (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678CrossRef Wellcome Trust Case Control Consortium, Burton PR, Clayton DG et al (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678CrossRef
8.
go back to reference Willer CJ, Speliotes EK, Loos RJ et al (2009) Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41:25–34CrossRefPubMedPubMedCentral Willer CJ, Speliotes EK, Loos RJ et al (2009) Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41:25–34CrossRefPubMedPubMedCentral
9.
go back to reference Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645CrossRefPubMedPubMedCentral Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645CrossRefPubMedPubMedCentral
10.
go back to reference Lenz TL, Deutsch AJ, Han B et al (2015) Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet 47:1085–1090 Lenz TL, Deutsch AJ, Han B et al (2015) Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet 47:1085–1090
11.
go back to reference Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39:770–775CrossRefPubMed Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39:770–775CrossRefPubMed
12.
go back to reference McCarthy MI, Abecasis GR, Cardon LR et al (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9:356–369CrossRefPubMed McCarthy MI, Abecasis GR, Cardon LR et al (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9:356–369CrossRefPubMed
13.
go back to reference Sudlow C, Gallacher J, Allen N et al (2015) UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12, e1001779CrossRefPubMedPubMedCentral Sudlow C, Gallacher J, Allen N et al (2015) UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12, e1001779CrossRefPubMedPubMedCentral
16.
go back to reference Yang J, Wray NR, Visscher PM (2010) Comparing apples and oranges: equating the power of case–control and quantitative trait association studies. Genet Epidemiol 34:254–257CrossRefPubMed Yang J, Wray NR, Visscher PM (2010) Comparing apples and oranges: equating the power of case–control and quantitative trait association studies. Genet Epidemiol 34:254–257CrossRefPubMed
17.
go back to reference Claussnitzer M, Dankel SN, Kim KH et al (2015) FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 373:895–907CrossRefPubMed Claussnitzer M, Dankel SN, Kim KH et al (2015) FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 373:895–907CrossRefPubMed
18.
go back to reference Zhu Z, Bakshi A, Vinkhuyzen AA et al (2015) Dominance genetic variation contributes little to the missing heritability for human complex traits. Am J Hum Genet 96:377–385CrossRefPubMedPubMedCentral Zhu Z, Bakshi A, Vinkhuyzen AA et al (2015) Dominance genetic variation contributes little to the missing heritability for human complex traits. Am J Hum Genet 96:377–385CrossRefPubMedPubMedCentral
19.
go back to reference Wojciechowski P, Lipowska A, Rys P et al (2012) Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia 55:2636–2645CrossRefPubMedPubMedCentral Wojciechowski P, Lipowska A, Rys P et al (2012) Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia 55:2636–2645CrossRefPubMedPubMedCentral
20.
go back to reference Wood AR, Hernandez DG, Nalls MA et al (2011) Allelic heterogeneity and more detailed analyses of known loci explain additional phenotypic variation and reveal complex patterns of association. Hum Mol Genet 20:4082–4092CrossRefPubMedPubMedCentral Wood AR, Hernandez DG, Nalls MA et al (2011) Allelic heterogeneity and more detailed analyses of known loci explain additional phenotypic variation and reveal complex patterns of association. Hum Mol Genet 20:4082–4092CrossRefPubMedPubMedCentral
21.
go back to reference Wood AR, Tuke MA, Nalls MA et al (2014) Another explanation for apparent epistasis. Nature 514:E3–E5CrossRefPubMed Wood AR, Tuke MA, Nalls MA et al (2014) Another explanation for apparent epistasis. Nature 514:E3–E5CrossRefPubMed
Metadata
Title
Variants in the FTO and CDKAL1 loci have recessive effects on risk of obesity and type 2 diabetes, respectively
Authors
Andrew R. Wood
Jessica Tyrrell
Robin Beaumont
Samuel E. Jones
Marcus A. Tuke
Katherine S. Ruth
Hanieh Yaghootkar
Rachel M. Freathy
Anna Murray
Timothy M. Frayling
Michael N. Weedon
The GIANT consortium
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 6/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-3908-5

Other articles of this Issue 6/2016

Diabetologia 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine